vs

Side-by-side financial comparison of Alignment Healthcare, Inc. (ALHC) and Sensata Technologies Holding plc (ST). Click either name above to swap in a different company.

Alignment Healthcare, Inc. is the larger business by last-quarter revenue ($1.2B vs $934.8M, roughly 1.3× Sensata Technologies Holding plc). Sensata Technologies Holding plc runs the higher net margin — 9.3% vs 0.9%, a 8.4% gap on every dollar of revenue. On growth, Sensata Technologies Holding plc posted the faster year-over-year revenue change (2.6% vs -74.7%). Over the past eight quarters, Alignment Healthcare, Inc.'s revenue compounded faster (34.6% CAGR vs -5.0%).

Alignment Healthcare, Inc. is a U.S.-based healthcare provider offering Medicare Advantage plans for seniors. It adopts a value-based care model, partnering with local providers to deliver personalized coordinated medical services, prescription drug coverage and supplemental benefits to members across multiple U.S. states.

Sensata Technologies Holding plc is a global industrial technology company that designs, manufactures and sells a broad portfolio of sensing, electrical protection and control solutions. Its products serve automotive, industrial, aerospace, HVAC, telecommunications and heavy vehicle end markets, catering to manufacturing and enterprise clients across the world.

ALHC vs ST — Head-to-Head

Bigger by revenue
ALHC
ALHC
1.3× larger
ALHC
$1.2B
$934.8M
ST
Growing faster (revenue YoY)
ST
ST
+77.3% gap
ST
2.6%
-74.7%
ALHC
Higher net margin
ST
ST
8.4% more per $
ST
9.3%
0.9%
ALHC
Faster 2-yr revenue CAGR
ALHC
ALHC
Annualised
ALHC
34.6%
-5.0%
ST

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
ALHC
ALHC
ST
ST
Revenue
$1.2B
$934.8M
Net Profit
$11.4M
$87.1M
Gross Margin
30.6%
Operating Margin
15.1%
Net Margin
0.9%
9.3%
Revenue YoY
-74.7%
2.6%
Net Profit YoY
24.6%
EPS (diluted)
$0.59

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALHC
ALHC
ST
ST
Q1 26
$1.2B
$934.8M
Q4 25
$1.0B
$917.9M
Q3 25
$993.7M
$932.0M
Q2 25
$1.0B
$943.4M
Q1 25
$926.9M
$911.3M
Q4 24
$701.2M
$907.7M
Q3 24
$692.4M
$982.8M
Q2 24
$681.3M
$1.0B
Net Profit
ALHC
ALHC
ST
ST
Q1 26
$11.4M
$87.1M
Q4 25
$-11.0M
$63.2M
Q3 25
$3.7M
$-162.5M
Q2 25
$15.7M
$60.7M
Q1 25
$-9.1M
$69.9M
Q4 24
$-31.1M
$5.8M
Q3 24
$-26.4M
$-25.0M
Q2 24
$-24.0M
$71.7M
Gross Margin
ALHC
ALHC
ST
ST
Q1 26
30.6%
Q4 25
29.0%
Q3 25
27.8%
Q2 25
30.3%
Q1 25
29.9%
Q4 24
27.1%
Q3 24
28.6%
Q2 24
30.0%
Operating Margin
ALHC
ALHC
ST
ST
Q1 26
15.1%
Q4 25
-1.0%
10.9%
Q3 25
0.8%
-13.2%
Q2 25
2.2%
14.6%
Q1 25
-0.6%
13.4%
Q4 24
-3.2%
8.1%
Q3 24
-2.8%
-20.3%
Q2 24
-2.7%
12.5%
Net Margin
ALHC
ALHC
ST
ST
Q1 26
0.9%
9.3%
Q4 25
-1.1%
6.9%
Q3 25
0.4%
-17.4%
Q2 25
1.5%
6.4%
Q1 25
-1.0%
7.7%
Q4 24
-4.4%
0.6%
Q3 24
-3.8%
-2.5%
Q2 24
-3.5%
6.9%
EPS (diluted)
ALHC
ALHC
ST
ST
Q1 26
$0.59
Q4 25
$-0.04
$0.45
Q3 25
$0.02
$-1.12
Q2 25
$0.07
$0.41
Q1 25
$-0.05
$0.47
Q4 24
$-0.15
$0.05
Q3 24
$-0.14
$-0.17
Q2 24
$-0.13
$0.47

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALHC
ALHC
ST
ST
Cash + ST InvestmentsLiquidity on hand
$705.6M
$635.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$206.9M
$2.9B
Total Assets
$1.3B
$6.8B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALHC
ALHC
ST
ST
Q1 26
$705.6M
$635.1M
Q4 25
$604.2M
$573.0M
Q3 25
$644.1M
$791.3M
Q2 25
$503.8M
$661.8M
Q1 25
$479.5M
$588.1M
Q4 24
$470.6M
$593.7M
Q3 24
$381.0M
$506.2M
Q2 24
$363.7M
$1.0B
Total Debt
ALHC
ALHC
ST
ST
Q1 26
Q4 25
$323.2M
$2.8B
Q3 25
$322.7M
Q2 25
$322.3M
Q1 25
$321.9M
Q4 24
$321.4M
$3.2B
Q3 24
$212.0M
Q2 24
$211.7M
Stockholders' Equity
ALHC
ALHC
ST
ST
Q1 26
$206.9M
$2.9B
Q4 25
$179.3M
$2.8B
Q3 25
$161.9M
$2.7B
Q2 25
$141.0M
$2.9B
Q1 25
$108.1M
$2.8B
Q4 24
$99.9M
$2.9B
Q3 24
$114.5M
$3.0B
Q2 24
$123.7M
$3.0B
Total Assets
ALHC
ALHC
ST
ST
Q1 26
$1.3B
$6.8B
Q4 25
$1.1B
$6.8B
Q3 25
$1.1B
$7.1B
Q2 25
$1.0B
$7.3B
Q1 25
$895.6M
$7.2B
Q4 24
$782.1M
$7.1B
Q3 24
$692.3M
$7.3B
Q2 24
$716.3M
$8.2B
Debt / Equity
ALHC
ALHC
ST
ST
Q1 26
Q4 25
1.80×
1.02×
Q3 25
1.99×
Q2 25
2.29×
Q1 25
2.98×
Q4 24
3.22×
1.11×
Q3 24
1.85×
Q2 24
1.71×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALHC
ALHC
ST
ST
Operating Cash FlowLast quarter
$128.7M
$122.5M
Free Cash FlowOCF − Capex
$104.6M
FCF MarginFCF / Revenue
11.2%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
11.27×
1.41×
TTM Free Cash FlowTrailing 4 quarters
$508.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALHC
ALHC
ST
ST
Q1 26
$128.7M
$122.5M
Q4 25
$-50.4M
$201.5M
Q3 25
$144.6M
$159.9M
Q2 25
$29.1M
$140.9M
Q1 25
$16.6M
$119.2M
Q4 24
$-8.7M
$170.7M
Q3 24
$26.2M
$130.9M
Q2 24
$23.5M
$143.5M
Free Cash Flow
ALHC
ALHC
ST
ST
Q1 26
$104.6M
Q4 25
$-55.4M
$151.9M
Q3 25
$139.1M
$136.2M
Q2 25
$21.1M
$115.5M
Q1 25
$8.4M
$86.6M
Q4 24
$-18.0M
$138.9M
Q3 24
$16.9M
$91.3M
Q2 24
$11.8M
$98.4M
FCF Margin
ALHC
ALHC
ST
ST
Q1 26
11.2%
Q4 25
-5.5%
16.6%
Q3 25
14.0%
14.6%
Q2 25
2.1%
12.2%
Q1 25
0.9%
9.5%
Q4 24
-2.6%
15.3%
Q3 24
2.4%
9.3%
Q2 24
1.7%
9.5%
Capex Intensity
ALHC
ALHC
ST
ST
Q1 26
Q4 25
0.5%
5.4%
Q3 25
0.6%
2.5%
Q2 25
0.8%
2.7%
Q1 25
0.9%
3.6%
Q4 24
1.3%
3.5%
Q3 24
1.3%
4.0%
Q2 24
1.7%
4.4%
Cash Conversion
ALHC
ALHC
ST
ST
Q1 26
11.27×
1.41×
Q4 25
3.19×
Q3 25
38.77×
Q2 25
1.86×
2.32×
Q1 25
1.70×
Q4 24
29.50×
Q3 24
Q2 24
2.00×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons